欧洲大肠杆菌检测市场预测至 2027 年 - COVID-19 影响和区域技术分析(单克隆抗体、差异光散射、分子诊断、免疫测定、色谱、流式细胞术、凝胶微滴和诊断成像);最终用户(商业或私人实验室、医生办公室、医院、公共卫生实验室和学术研究机构)和国家/地区

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 125    |    Report Code: TIPRE00012195    |    Category: Consumer Goods

Europe E. coli Testing Market

市场介绍

大肠杆菌(E. coli)是杆状革兰氏阴性细菌。这些细菌是腹泻病的主要原因,尤其是儿童腹泻病,主要通过被动物或人类粪便污染的食物或饮用水摄入。某些大肠杆菌菌株会产生志贺毒素,导致胃肠道 (GI) 感染和医疗并发症,如胃肠道感染、胆管炎、胆囊炎、菌血症、新生儿脑膜炎和肺炎、尿路感染 (UTI)。如果不治疗,这种综合征可能会导致肾衰竭等有害结果。大肠杆菌测试用于利用粪便样本诊断胃肠道感染。这些测试可以使用分子诊断试剂盒和免疫分析进行。

市场概况和动态

欧洲E.大肠杆菌市场预计将从 2019 年的 4.427 亿美元增至 2027 年的 7.265 亿美元。预计 2019 年至 2027 年该市场将以 6.5% 的复合年增长率增长。研究活动预计将促进大肠杆菌市场的增长。然而,市场可能会受到预测期内测试挑战等风险因素的影响。

关键细分市场

从技术角度来看,单克隆抗体领域在欧洲占据最大份额。 2019 年的 colitesting 市场。公共卫生实验室领域占欧洲的最大份额。 2019 年按最终用户划分的 colitestingmarket。

主要来源和上市公司

与 EuropeE 相关的几个主要的一手和二手来源。 colitestingmarket 报告由世界卫生组织 (WHO)、欧洲疾病预防和控制中心 (ECDC) 等机构提供。

原因购买报告

  • 它提供了对欧洲大肠杆菌测试市场格局的了解,并确定了最有可能保证强大的大肠杆菌测试市场细分返回。
  • 它通过了解欧洲不断变化的竞争格局来指导保持领先地位。大肠杆菌测试市场。
  • 它通过识别最有可能销售的细分市场,帮助有效规划大肠杆菌市场的并购和合作伙伴交易
  • 它通过对 E 的敏锐而全面的分析,促进明智的业务决策。 colite 与欧洲相关的各个细分市场的市场表现。大肠杆菌检测市场。
  • 它提供E. colitestingmarket 根据 2019 年至 2027 年各个细分市场的市场收入预测。

欧洲。 COLI测试市场细分

按技术

  • 单克隆抗体
  • 差异光散射
  • 分子诊断
  • 免疫测定
  • 色谱法
  • 流式细胞仪
  • 凝胶微滴
  • 诊断成像

最终用户

    < li>商业或私人实验室
  • 医生办公室
  • 医院
  • 公共卫生实验室
  • 学术研究机构

按国家/地区

  • 英国
  • 德国
  • 法国< /span>
  • 意大利
  • 西班牙

公司简介

  • bioMerieux SA
  • 雅培 (Alere Inc.)< /li>
  • BD
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.

 



Europe E. coli Testing Strategic Insights

Strategic insights for Europe E. coli Testing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-e-coli-testing-market-strategic-framework.webp
Get more information on this report

Europe E. coli Testing Report Scope

Report Attribute Details
Market size in 2019 US$ 442.7 Million
Market Size by 2027 US$ 726.5 Million
Global CAGR (2019 - 2027) 6.5%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 技术
  • 单克隆抗体
  • 差分光散射
  • 分子诊断
  • 免疫测定
  • 色谱法
  • 流式细胞术
  • 凝胶微滴
  • 诊断成像
By 最终用户
  • 商业或私人实验室
  • 医生办公室
  • 医院
  • 公共卫生实验室
  • 学术研究机构
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • bioMerieux SA
  • Abbott (Alere Inc.)
  • BD
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.
  • Get more information on this report

    Europe E. coli Testing Regional Insights

    The regional scope of Europe E. coli Testing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-e-coli-testing-market-geography.webp
    Get more information on this report

    The List of Companies - Europe E. coli Testing Market

    The List of Companies - Europe E. coli Testing Market

    1. bioMerieux SA
    2. Abbott (Alere Inc.)
    3. BD
    4. Thermo Fisher Scientific, Inc.
    5. Hologic, Inc.

     

    Frequently Asked Questions
    How big is the Europe E. coli Testing Market?

    The Europe E. coli Testing Market is valued at US$ 442.7 Million in 2019, it is projected to reach US$ 726.5 Million by 2027.

    What is the CAGR for Europe E. coli Testing Market by (2019 - 2027)?

    As per our report Europe E. coli Testing Market, the market size is valued at US$ 442.7 Million in 2019, projecting it to reach US$ 726.5 Million by 2027. This translates to a CAGR of approximately 6.5% during the forecast period.

    What segments are covered in this report?

    The Europe E. coli Testing Market report typically cover these key segments-

  • 技术 (单克隆抗体, 差分光散射, 分子诊断, 免疫测定, 色谱法, 流式细胞术, 凝胶微滴, 诊断成像)
  • 最终用户 (商业或私人实验室, 医生办公室, 医院, 公共卫生实验室, 学术研究机构)
  • What is the historic period, base year, and forecast period taken for Europe E. coli Testing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe E. coli Testing Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Europe E. coli Testing Market?

    The Europe E. coli Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • bioMerieux SA
  • Abbott (Alere Inc.)
  • BD
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.
  • Who should buy this report?

    The Europe E. coli Testing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe E. coli Testing Market value chain can benefit from the information contained in a comprehensive market report.